oldid152109

Tudorache family businesses generate 150m euros

The companies owned by the Tudorache family, who control Montero pharmaceutical group, consolidated under investment vehicle Newarch Investments, are expected to generate revenues worth 150m euros this year, with the largest contribution (100m euros) coming fr...